netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Search
 Formulary Chapter 11: Eye - Full Chapter
11.08.01  Expand sub section  Tear deficiency, ocular lubricants, and astringents
 note  Use products in line with Leicestershire Guide to Prescribing Ocular Lubricants Please see individual product entries for detail on preservative contained.
(BZCL is benzalkonium chloride, which may cause ocular irritation; purite is a biodegradable low allergenic preservative system).
Preservative free drops are only indicated if:-
  • There is known toxicity or allergy to preservatives.
  • Drops are required 4 times a day or more in the presence of tear deficiency or epithelial instability.
  • Patients wearing preservative retaining contact lenses.
Hypromellose Eye drops 0.3%
View adult BNF View SPC online  Track Changes
First Choice
Green
Mucin-like effects and is also of benefit when the watery component of tears is deficient. (May contain BZCL)

 
Simple eye ointment BP
View adult BNF View SPC online  Track Changes
First Choice
Green
A bland ointment, which can be used on dry eyes at night, or applied when corneal drying must be avoided in anaesthetised or unconscious patients.
(Preservative free) 
Optive Plus
 Track Changes
First Choice
Green
(Contains purite) 
Sodium hyaluronate 0.1% (Hylo-Tear)
 Track Changes
First Choice
Green
For severe dry eye
(Preservative free) 
Polyvinyl Alchohol 1.4% (Sno Tears )
View adult BNF View SPC online  Track Changes
Formulary
Green
Help to form a tear film.
(Contains BZCL)
 
   
Carbomers 980 0.2% Gel (Clinitas Carbomer Gel)
View adult BNF View SPC online  Track Changes
Formulary
Green
Helps to form a tear film.
(Contains cetrimide)
 
   
Hydroxypropyl guar (Systane)
(unit dose vials)
View adult BNF View SPC online  Track Changes
Formulary
Green
(Preservative free) 
   
Carmellose 1% (PF Drops Carmellose 1%)
View adult BNF View SPC online  Track Changes
Formulary
Green
(Preservative free) 
   
Sodium hyaluronate 0.2% (Hylo-Forte)
 Track Changes
Formulary (Preservative free) 
   
Sodium hyaluronate, co-enzyme Q10, Vitamin E (VisuXL)
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Green

Severe dry eye and corneal healing post-surgery

 
Link  Leicestershire Evaluation: VisuXL in Severe Dry Eye Disease
   
Lacri-Lube
View adult BNF View SPC online  Track Changes
Formulary
Green
(Preservative free) 
   
Liquid paraffin plus Vitamin A eye ointment (VitA-POS)
View adult BNF View SPC online  Track Changes
Formulary (Preservative free) 
   
Xailin Night eye ointment
View adult BNF View SPC online  Track Changes
Formulary
Green
Contains white soft paraffin, white mineral oil and lanolin alcohols. (Preservative free). 
   
Carmellose 0.5% plus sodium hyaluronate 0.1% (Optive Fusion)
View adult BNF  Track Changes
Formulary
Green
(contains purite) 
   
Sodium Chloride 0.9%
View adult BNF View SPC online
Restricted Drug Restricted
Green
Single use eye drops. Sterile solution for irrigation.
These preparations are commonly used to remove irritants and foreign bodies from the eye. They are also useful as irrigation where eyelid disease prevents secretion by meibomian glands. A new (sealed) pack of irrigation solution should be used for each patient to prevent cross-contamination. Any contents remaining after use should be discarded. 
   
SystaneBalance
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Green
(contains polyquaternium-1)
For treatment of meibomian gland disease 
   
Acetylcysteine 10%
(unlicensed)
 Track Changes
Restricted Drug Restricted
Amber Simple
(Preservative free) 
   
Sodium chloride 5%
(unlicensed)
 Track Changes
Restricted Drug Restricted
Amber Simple
(Preservative free)
Drops and ointment available 
   
Systane Ultra
 Track Changes
Restricted Drug Restricted
Amber Simple
(Preservative free) 
   
Ciclosporin ophthalmic emulsion  (Ikervis)
View adult BNF View SPC online  Track Changes
Restricted Drug Restricted
Amber Simple
Specialist ophthalmologist initiation for use in line with NICE TA 369 only for treating severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes.

Date of entry of decision to Formulary: March 2016

 
Link  NICE TA 369: Ciclosporin for treating dry eye disease that has not improved...
   
 ....
 Non Formulary Items
Cenegermin  (Oxervate®)

View adult BNF View SPC online Track Changes
Non Formulary
Black

Not recommended by NICE TA 532 for Neurotrophic keratitis

Link  NICE TA 532: Cenegermin for treating neurotrophic keratitis
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety. All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry   

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).  

Amber SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.   

Amber Simple

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.  

Green Conditional

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.   

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.   

netFormulary